Showing results (21-30 of 913) with videos related to

Sort By:
Pageof 92
Pharmaceuticals (Basel, Switzerland)|June 28, 2023
Gout Remission as a Goal of Urate-Lowering Therapy: A Critical ReviewAdwoa Dansoa Tabi-Amponsah, Sarah Stewart, Graham Hosie, et al.
Arthritis Research & Therapy|November 14, 2019
Population-specific factors associated with fractional excretion of uric acidRavi K Narang, Zoe Vincent, Amanda Phipps-Green, et al.
Arthritis Care & Research|June 18, 2025
Time Trends and Predictors of Gout Remission Over 6 YearsAdwoa Dansoa Tabi-Amponsah, Sarah Stewart, Greg Gamble, et al.
The Lancet. Rheumatology|February 7, 2022
Gout and the risk of COVID-19 diagnosis and death in the UK Biobank: a population-based studyRuth K Topless, Angelo Gaffo, Lisa K Stamp, et al.
Annals of the Rheumatic Diseases|June 19, 2025
The Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) definition of clinical remission in goutAdwoa Dansoa Tabi-Amponsah, Sarah Stewart, Lisa K Stamp, et al.
Arthritis Care & Research|December 23, 2024
Gout Flares After Stopping Anti-Inflammatory Prophylaxis: A Rapid Literature Review and Meta-AnalysisLisa K Stamp, Christopher Frampton, Jeff A Newcomb, et al.
The Journal of Rheumatology|November 15, 2024
Association of Past Smoking Status With Gout in Māori People in Aotearoa New ZealandNiamh C Fanning, John F Pearson, Nicola Dalbeth, et al.
Pharmacogenetics and Genomics|June 8, 2015
A human leukocyte antigen locus haplotype confers risk for allopurinol-related adverse effects in Caucasian patients with goutRebecca L Roberts, Mary C Wallace, Andrew Harrison, et al.
Arthritis Care & Research|January 3, 2025
Relationship Between Gout Flare States and Patient-Reported Outcomes After Allopurinol InitiationLisa K Stamp, Chris Frampton, Sarah Stewart, et al.
Rheumatology (Oxford, England)|June 29, 2025
Mapping monosodium urate crystal deposition within metatarsophalangeal joints in tophaceous gout: a dual-energy CT studyChamaya De Silva, Cèsar Díaz-Torné, Greg Gamble, et al.
Pageof 92